dpp 4 inhibitors glp 1 Dipeptidyl peptidase in the treatment of type 2 diabetes mellitus Cardiovascular effects of DPP-4 inhibition:

Nerve Protection: Investigated for preventing peripheral neuropathy (numbness/tingling) caused by drugs like Cisplatin or Taxanes

Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation

These peptide signals are integrated with higher-level endocrine feedback

These findings underscore the significant role of TB-500 in promoting cardiac recovery under conditions of reduced oxygen supply, indicating its potential as a therapeutic agent for cardiac-related conditions

Phenformin In the late 1950s, Phenformin was introduced in the United States for the treatment of non-insulin-dependent (NIDDM) and was 50 times more powerful than metformin